Efficacy of a Physician-Led Multiparametric Telemonitoring
System in Very Old Adults with Heart Failure
†
Claudio Pedone, MD, PhD,* Francesca Flavia Rossi, MD,* Annagrazia Cecere, MD,*
‡
Luisa Costanzo, MD,* and Raffaele Antonelli Incalzi, MD*
Key words: aged; heart failure; long-term care; preven-
OBJECTIVES: To evaluate the effect of an innovative tion; telemedicine
model integrating telemonitoring of vital parameters and
telephone support on 6-month survival and hospital admis-
sions of elderly adults with heart failure (HF).
DESIGN: Parallel-arm, randomized trial.
SETTING: Geriatric acute care ward and outpatient clinic
at Policlinico Campus Biomedico (Rome, Italy).
PARTICIPANTS: Individuals with HF aged 65 and older
(mean age 80) randomly assigned to intervention (n = 50)
or control (n = 46). Participants had an average ejection Several strategies have been tested to prevent rehospital-
ization of individuals with heart failure (HF),1,2 includ-
fraction of 46%.
ing telemedicine and telemonitoring. According to a
INTERVENTION: Telemonitoring system (receives and
Cochrane revision, telemedicine has the potential for
communicates oxygen saturation, heart rate, and blood
improving health care and reducing healthcare expendi-
pressure readings) and office-hours telephonic support pro-
tures for individuals with HF,3 but results of more-recent
vided by a geriatrician.
trials have been disappointing. In the Telemedical Interven-
MEASUREMENTS: Combination of all-cause death and
tional Monitoring in Heart Failure (TIM-HF) trial, mortal-
hospital admissions.
ity did not change despite monitoring of blood pressure,
RESULTS: The two groups were similar with the excep- electrocardiogram, and body weight.4 In the Telemonitor-
tion of the prevalence of women and of disability (both
ing to Improve Heart Failure Outcomes trial, an automatic
more common in the control group). Three patients for
telephone-based daily collection of information about
each group were lost to follow-up (final analyzed sample
symptoms and body weight did not improve the out-
size: 90). Incidence of the main outcome was 42% in the comes,5 whereas the CardioMEMS Heart Sensor Allows
control group and 21% in the intervention group (relative
Monitoring of Pressure to Improve Outcomes in NYHA
risk = 0.51, 95% confidence interval (CI) = 0.26–0.98).
Class III Patients trial, using an implantable hemodynamic
The results were unchanged after taking into account the
telemonitoring system, demonstrated a significant decrease
setting of enrollment, sex, and disability (hazard
of the rate of rehospitalization.6 Other trials using
ratio = 0.42, 95% CI = 0.19–0.94).
implantable devices or noninvasive
telemonitoring7–9
CONCLUSION: Telemonitoring ofelderly people withHF
yielded inconclusive results.
isfeasible andreduces therisk ofdeath andhospitalization.
A comparative analysis of randomized clinical trials
Furtherstudiesareneededtoconfirmthesefindingsandeval-
shows that they differ in the number and type of biological
uate the cost-efficacy of the service. J Am Geriatr Soc
signals monitored, in the timing of recording, and in the
63:1175–1180,2015.
organization of the medical support.10 Furthermore, in
these trials, the attending physicians did not directly moni-
tor the participants. The current study was planned to
evaluate whether a telemonitoring system providing infor-
Fromthe*AreadiGeriatria,Universit(cid:1)aCampusBio-MedicodiRoma; mation directly to the physician in charge of individuals’
†FondazioneAlbertoSordi,Romeand‡FondazioneSanRaffaele, care and including telephone support could prevent hospi-
CittadelladellaCarit(cid:1)a,Taranto,Italy. tal readmissions and death in elderly adults with HF. It
AddresscorrespondencetoLuisaCostanzo,AreadiGeriatria,Universit(cid:1)a was hypothesized that a system directly supervised by the
(cid:3)
CampusBio-MedicodiRoma,ViaAlvarodelPortillo21,Roma00128, attending physician would make therapeutic interventions
Italy.E-mail:l.costanzo@unicampus.it more timely and effective.
DOI:10.1111/jgs.13432
JAGS 63:1175–1180,2015
©2015,CopyrighttheAuthors
Journalcompilation©2015,TheAmericanGeriatricsSociety 0002-8614/15/$15.00
1176 PEDONEETAL. JUNE2015–VOL. 63, NO. 6 JAGS
ened or new symptoms had arisen. In this event, the par-
METHODS
ticipant’s adherence to therapy was checked, and if it was
unsatisfactory, interventions promoting adherence were
Study Design
administered. Based on the participant’s symptoms and
This was a single-center, unmasked, randomized trial with signs, an office appointment was scheduled or the partici-
6 months of follow-up comparing multiparametric pant was referred to the staff of the acute care ward, who
telemonitoring plus telephonic support with standard care. made the final decision on the admission and was blinded
Individuals with a first diagnosis of HF were recruited to participant allocation.
from the geriatric acute care ward of a teaching hospital, All participants in the intervention group also received
and those with a principal diagnosis of HF were recruited standard care (see below).
from the outpatient clinic of the same hospital.
HF was diagnosed on the basis of symptoms, objective
Standard Care
evidence (including echocardiography when available), lab-
oratory data (N-terminal prohormone of brain natriuretic Individuals discharged from the acute care ward received
peptide (NT-proBNP) when available), and response to detailed instructions about medical therapy and lifestyle
specific therapy.11 The only inclusion parameter other than counseling, and a follow-up visit was scheduled for
diagnosis of HF was age of 65 and older. The exclusion 1 month after discharge. A geriatrician was available on
criterion was severe cognitive impairment. The ethical week days for 2 hours per day for telephonic support, and
committee of the Campus Biomedico University in Rome participants recruited from the acute care ward and the
approved the study protocol (#09/2012), which is regis- outpatient clinic were followed up in visits based on their
tered at www.clinicaltrials.gov (NCT0191458). clinical conditions and were seen by geriatricians from the
same unit as the study researchers, who were blinded to
their study allocation.
Intervention
The intervention included a telemonitoring system and
Multidimensional Assessment
office-hours telephonic support provided by a geriatrician
whohadaccesstothetelemonitoringsystem.Thetelephonic Activities of daily living (ADLs, range 0–6 lost functions),
contactswerenotscheduled;participantswereinstructedto instrumental activities of daily living (IADLs, range 0–8
usethischannelofcommunicationtoreportnewsymptoms lost functions), and New York Heart Association (NYHA)
orproblemswiththetelemonitoringsystem. class were rated. Comorbidity burden was expressed using
The telemonitoring system consists of commercial the Cumulative Illness Rating Scale (CIRS),12 which has
measurement devices equipped with a transmitter and a two scales: a comorbidity scale indicating the number of
commercial android-based smartphone that receives from systems with a clinically relevant disease (range 0–13), and
the transmitter the readings from the measurement instru- a severity scale (range 1–5, with higher values indicating
ments, communicates the readings to the central compo- more-severe conditions). Serum concentration of NT-proB-
nent of the system in real time, and issues reminders to the NP was measured on admission, and the use of cardiovas-
patient when measurement is scheduled. The measurement cular drugs (diuretics, angiotensin-converting enzyme
instruments provided to participants were a sphygmoma- inhibitors (ACE-Is) and angiotensin receptor blockers
nometer (A & D Engineering, San Jose, CA), a scale (A & (ARB), beta-blockers, statins, nitrates) was recorded.
D Engineering), and a pulse oximeter (Nonin Medical Inc.,
Plymouth, MN).
Outcome
To avoid heterogeneity, the same baseline scheduling
was used for all participants throughout the study: weight Outcome measures were hospital admissions for any rea-
once a day; blood pressure and heart rate twice a day, and son or death 180 days from enrollment. All information
peripheral oxygen saturation three times a day. Partici- was gathered from clinical records, when available, or
pants could perform additional measurements in case of from in-person or telephone interviews.
symptoms, and the schedule of measurements could be
remotely altered to adapt it to the changing needs of the
Sample Size
participants. A monitoring system software allowed real-
time access to the information that the devices listed above An outcome incidence of 50% was anticipated.5 Because
gathered. The monitoring system was web-based and this was an exploratory study, it was decided to allow for
accessed through a secure connection using a standard In- a type I error rate of 10%. On these assumptions, it was
ternet browser. calculated that a sample size of 50 participants per group
A geriatrician evaluated the data received every day. would provide 80% power to detect a 25% absolute risk
The monitor system displayed an alert when a measure- reduction. As shown in Figure 1, 186 individuals meeting
ment was outside a predefined range, which could be cus- inclusion and exclusion criteria were identified; 90 of these
tomized for each participant, but the system was intended refused to participate. Of the remaining 96, 50 were ran-
for monitoring only, and participants were instructed to domized to the intervention group and 46 to the control
contact their usual healthcare provider in case of emer- group using a computer-generated random number list.
gency. Three participants in each group were lost to follow-up,
In case of abnormal readings, the physician contacted and four participants dropped out of the intervention
the participant to verify whether their symptoms had wors- group, leaving a final sample size for the analysis of 90.
JAGS JUNE2015–VOL. 63, NO. 6 TELEMEDICINEINOLDERADULTSWITHHEARTFAILURE 1177
Figure 1. Studyflowchart.
taken, or number of admissions in the preceding year.
Analytical Approach
Ninety-one percent of participants were taking loop diuret-
Descriptivestatisticsandt-testsorchi-squaretestswereused ics, and approximately half were taking ACE-Is, ARBs, or
tocomparegroups.The riskofthecompositeoutcomewas beta-blockers, without significant differences between the
calculated using the product-limit method complemented two groups (Table 1).
with the log-rank test. The adjusted relative hazard for the On average, 62% of scheduled measurements were
outcome was estimated using a proportional hazards completed; adherence was best for pulse oximeter (70%)
model including site of enrollment (hospital ward or and worst for the scale (56%). Sixty-four percent of partic-
ambulatory setting) as a random effect term. In this model, ipants completed at least half of the scheduled measure-
the number of ADLs was dichotomized using the median ments.
(3) as a cutoff variable to avoid the assumption of a linear There were 28 hospital admissions during the
relationship with the outcome risk. All analyses were per- 6 months of follow-up (incidence rate 77.9/100 person-
formed using an intention-to-treat approach. The analyses years, 95% confidence interval (CI) = 54–112.6), 20 in
were performed using R Statistical Software version 2.14 the control group (incidence rate 129/100 person-years,
for Linux. 95% CI = 84–200) and eight (incidence rate 39/100 per-
son-years, 95% CI = 20–77) in the intervention group
(incidence rate ratio = 0.30, 95% CI = 0.12–0.67). Half
RESULTS
of the admissions were due to heart failure or related
The mean age of the sample (80 (cid:1) 7, range 60–94) was heart diseases (e.g., arrhythmias). More admissions were
similar in the two groups, whereas the proportion of men due to cardiac events in the telemonitoring group (62.5%)
was higher in the telemonitoring group (47%, vs 30% in than in the control group (45%), although the incidence
the control group). Independence in ADLs was better pre- rate ratio for heart failure hospitalizations was 0.48
served in the telemonitoring group, but there were no dif- (0.14–1.45). The number of observed deaths was 10,
ferences in the distribution of NYHA class, comorbidity seven in the control group (incidence rate 37/100 person-
score, NT-proBNP serum concentration, number of drugs years, 95% CI = 18–76) and three in the intervention
1178 PEDONEETAL. JUNE2015–VOL. 63, NO. 6 JAGS
Table 1. Characteristics of the Sample
Characteristic Control,n=43 Telemonitoring,n=47 P-Value
Age,mean (cid:1) SD 79.7 (cid:1) 7.8 79.9 (cid:1) 6.8 .88
Male,% 30.2 46.8 .16
Numberofactivitiesofdailylivinglost,mean (cid:1) SD 3 (cid:1) 1.4 2.1 (cid:1) 1.9 .01
Numberofinstrumentalactivitiesofdailylivinglost,mean (cid:1) SD 5 (cid:1) 1.4 4.1 (cid:1) 1.9 .01
NewYorkHeartAssociationClass,%
II 32.6 31.9 >.99
III 55.8 57.4 >.99
IV 11.6 10.6 >.99
CumulativeIllnessRatingScalescore,mean (cid:1) SD
Severity(range1–5) 1.5 (cid:1) 0.2 1.5 (cid:1) 0.2 .32
Comorbidity(range0–13) 1.6 (cid:1) 0.5 1.5 (cid:1) 0.6 .70
N-terminalprohormoneofbrainnatriureticpeptide,ng/mL,mean (cid:1) SD 7,055.9 (cid:1) 10,605.3 9,030.9 (cid:1) 13,592.2 .51
Ejectionfraction,%,mean (cid:1) SD 48.2 (cid:1) 13.5 44.4 (cid:1) 12.7 .24
Diabetesmellitus,% 34.3 31.9 .94
Renalinsufficiency,% 27.9 29.8 >.99
Numberofhospitaladmissionsinthepreviousyear,mean (cid:1) SD 0.7 (cid:1) 0.7 0.6 (cid:1) 0.6 .92
Numberofdrugs,mean (cid:1) SD 9.9 (cid:1) 3.2 9.6 (cid:1) 3.1 .66
Drugs,%
Beta-blocker 53.5 55.3 >.99
Loopdiuretic 86.0 95.7 .21
Potassium-sparingdiuretic 30.2 34.0 .87
Angiotensin-convertingenzymeinhibitororangiotensinreceptorblocker 60.5 55.3 .78
Nitrate 39.5 4.4 >.99
3-hydroxy-3-methyl-glutarylcoenzymeAreductaseinhibitors 27.9 25.5 .99
group (incidence rate 13/100 person-years, 95% CI = 5– was therefore hardly comparable with the current inter-
39). The incidence rate for the composite outcome was vention. The TIM-HF trial4 tested a system that was
112/100 person-years (95% CI = 82–154) in the overall similar to that used in the current study, but peripheral
population, 190/100 person-years in the control group, oxygen saturation was not included in the monitored
and 56/100 person-years in the intervention group; the parameters, and the parameters were collected only once
corresponding incidence rate ratio was 0.30 (95% CI = a day. Furthermore, the telemedical center provided
0.14–0.59). telephone support once a month, and participants could
The overall proportion of people experiencing the contact the telemedical centers only in case of emer-
composite outcome was 42% in the control group and gency. In addition, the population in the TIM-HF trial
21% in the telemonitoring group (relative risk = 0.51, was on average 13 years younger than in the current
95% CI = 0.26–0.98). Figure 2 shows the event-free sur- study.
vival of the two groups. The relative hazard for the com- A peculiarity of the current trial is that a geriatrician
posite outcome estimated using an unadjusted Cox led the intervention. HF prevalence increases with age,13
regression model was 0.43 (95% CI = 0.20–0.93). The with individuals with HF being on average 73 years old14
hazard ratio adjusted for sex, disability, and enrollment and having multiple comorbid diseases;15 the geriatrician
setting was 0.42 (95% CI = 0.19–0.94). Of the 10 out- typically provides comprehensive care customized to the
come events recorded in the intervention group, two complexity of these individuals.16 Another important fea-
occurred in people who dropped out of the study and two ture of the model is that it included “fast track” access
in participants with poor adherence who had not used the to ambulatory visits that was activated in case of abnor-
telemonitoring system in the days before the event. For the malities in the telemonitored data or when new symp-
other outcomes, a decline or instability of oxygen satura- toms ensued. Thus, a model of care was tested rather
tion preceded three; alteration in heart rate preceded two; than a simple telemonitoring system. This is an important
and oxygen desaturation, decline in blood pressure, and factor to be taken into account when evaluating tele-
weight gain preceded one. health interventions. The results of Whole Systems Dem-
onstrator,17 a large, community-based trial of telehealth,
indicate that the simple implementation of technologies in
DISCUSSION
the context of usual care is not enough to obtain sizable
These data suggest that a physician-led multiparametric benefits.18
telemonitoring system integrated with telephone support A formal cost-effectiveness analysis was not per-
can reduce the risk of all-cause death and hospitalization formed. The use of a physician rather than a nurse has an
in elderly adults with HF. The data are in contrast to obvious effect on costs, although this should be compared
those from two recent trials,4,5 but there are important with the cost of hospitalization; data from the current
differences between these trials. One intervention5 was study indicate that, for every 100 people with HF, the
based on a telephone-based voice response system and intervention may prevent 70 hospitalizations per year com-
pared with standard care. In addition, the telemonitoring indicate that telemonitoring could be more effective in the
hardware is inexpensive thanks to the use of commercial population for which it is intended, that is, individuals
devices, and on a large scale, this may in part offset the with difficulties attending frequent ambulatory visits. Sec-
costs of the service. Nonetheless, a direct evaluation is ond, results pertaining to medical outcomes were shown,
needed before any conclusions can be drawn. but an evaluation of economic and societal implications is
This study has several strengths. First, the very old needed before the effectiveness of the model of telehealth
individuals with HF studied are representative of the real- is established. Finally, the estimated risk reduction is larger
world target population. Second, the core of the techno- than found in previously published trials. Probably because
logical intervention does not lie in its hardware, which is of publication bias, small trials such as this one tend to
made up of existing, low-cost devices, but in its software overestimate the treatment effect.19 Furthermore, the
and monitoring system, with obvious implications for costs favorable results might depend partly on the experience in
on a large scale. The use of commercial devices also affects HF management of the geriatrician in charge of telemoni-
the acceptability of the system, because participants used tored individuals, although the control group also received
medical devices to which they were well accustomed. care from a geriatrician skilled in HF treatment.
Third, the availability of telephone contact on demand In conclusion, physician-led telemonitoring of elderly
could reassure people that telemonitoring is an add-on to, adults with HF is feasible and reduces the risk of death
not a substitute for, physician-patient contact. Finally, the and hospitalization. Further studies are needed to test this
monitoring schedule could be adapted to changing clinical model in a larger series and to assess its cost efficacy.
conditions.
Some limitations should also be taken into account. ACKNOWLEDGMENTS
First, the sample was small, with some imbalance in the
Conflict of Interest: The editor in chief has reviewed the
characteristics of the two groups. This may affect the
conflict of interest checklist provided by the authors and
internal validity of the study, although statistical correc-
tion for this imbalance has been performed. Moreover, the has determined that the authors have no financial or any
other kind of personal conflicts with this paper.
prevalence of physical impairment in the sample was high,
Author Contributions: Pedone, Incalzi: study concept
which makes generalization of the results to the gen-
and design. Pedone: data analysis and interpretation, prep-
eral HF population questionable, although the results may
gniniameR
fo
ytilibaborP
ro
gnivivruS
fo
ytilibaborP
gnivivruS
fo
ytilibaborP
noissimdaeR
fo
eerF
noissimdaeR
eerF
gniniameR
0.1
8.0
6.0
4.0
2.0
0.0
Control
Telemonitoring Log-rank P=.13
43 42 39 37 36 36 36 Control
47 47 46 45 45 44 44 Telemonitoring
0 30 60 90 120 150 180
Days
Control
Telemonitoring Log-rank P=.04
43 34 30 29 29 29 29 Control
47 45 42 40 40 40 40 Telemonitoring
0 30 60 90 120 150 180
Days
Control
Telemonitoring Log-rank P=.03
43 33 29 26 25 25 25 Control
47 45 41 38 38 37 37 Telemonitoring
0 30 60 90 120 150 180
Days
0.1
8.0
6.0
4.0
2.0
0.0
0.1
8.0
6.0
4.0
2.0
0.0
JAGS JUNE2015–VOL. 63, NO. 6 TELEMEDICINEINOLDERADULTSWITHHEARTFAILURE 1179
A
B
C
Figure 2. Kaplan-Meierestimate of (A) riskof death,(B) hospitaladmissions, and(C) composite outcome.
1180 PEDONEETAL. JUNE2015–VOL. 63, NO. 6 JAGS
aration of a draft of the manuscript, critical revision of the 8. Stevenson LW, Zile M, Bennett TD etal. Chronic ambulatory intracar-
article. Rossi, Cecere: participant recruitment, data collec- diac pressures and future heart failure events. Circ Heart Fail 2010;3:
580–587.
tion, drafting the paper. Costanzo: data collection and
9. TakahashiPY,PecinaJL,UpatisingBetal.Arandomizedcontrolledtrial
interpretation, revision of the manuscript. Incalzi: critical oftelemonitoringinolderadultswithmultiplehealthissuestopreventhos-
revision of the manuscript for important intellectual con- pitalizations and emergency department visits. Arch Intern Med
tent. All authors provided final approval of the version to
2012;172:773–779.
10. ClarkRA,InglisSC,McAlisterFAetal.Telemonitoringorstructuredtele-
be published.
phonesupportprogrammesforpatientswithchronicheartfailure:System-
Sponsor’s Role: No sponsor. aticreviewandmeta-analysis.BMJ2007;334:942.
11. McMurray JJV, Adamopoulos S, Anker SD etal. ESC guidelines for the
diagnosisandtreatmentofacuteandchronicheartfailure2012:TheTask
REFERENCES
ForcefortheDiagnosisandTreatmentofAcuteandChronicHeartFailure
2012 of the European Society of Cardiology. Developed in collaboration
1. Gheorghiade M, Vaduganathan M, Fonarow GC etal. Rehospitalization with the Heart Failure Association (HFA) of the ESC. Eur Heart J
for heart failure: Problems and perspectives. J Am Coll Cardiol 2012;33:1787–1847.
2013;61:391–403. 12. LinnBS,LinnMW,GurelL.Cumulativeillnessratingscale.JAmGeriatr
2. BradleyEH,CurryL,HorwitzLIetal.Contemporaryevidenceabouthos- Soc1968;16:622–626.
pital strategies for reducing 30-day readmissions: A national study. J Am 13. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart
CollCardiol2012;60:607–614. failure.Heart2000;83:596–602.
3. Inglis SC, Clark RA, McAlister FA etal. Structured telephone support or 14. Davies M, Hobbs F, Davis R etal. Prevalence of left-ventricular systolic
telemonitoringprogrammesforpatientswithchronicheartfailure.Cochra- dysfunction and heart failure in the Echocardiographic Heart of England
neDatabaseSystRev2010;8:CD007228. Screeningstudy:Apopulationbasedstudy.Lancet2001;358:439–444.
4. KoehlerF,WinklerS,SchieberMetal.Impactofremotetelemedicalman- 15. Saczynski JS, Go AS, Magid DJ etal. Patterns of comorbidity in older
agement on mortality and hospitalizations in ambulatory patients with adults with heart failure: The Cardiovascular Research Network PRE-
chronic heart failure: The Telemedical Interventional Monitoring in Heart SERVEstudy.JAmGeriatrSoc2013;61:26–33.
FailureStudy.Circulation2011;123:1873–1880. 16. Palmer RM. Geriatric assessment. Med Clin North Am 1999;83:1503–
5. ChaudhrySI,MatteraJA,CurtisJPetal.Telemonitoringinpatientswith 1523,vii–viii.
heartfailure.NEnglJMed2010;363:2301–2309. 17. SteventonA,BardsleyM,BillingsJetal.Effectoftelecareonuseofhealth
6. Abraham WT, Adamson PB, Bourge RC etal. Wireless pulmonary artery and social care services: Findings from the Whole Systems Demonstrator
haemodynamic monitoring in chronic heart failure: A randomised con- clusterrandomisedtrial.AgeAgeing2013;42:501–508.
trolledtrial.Lancet2011;377:658–666. 18. Gornall J. Does telemedicine deserve the green light? BMJ 2012;345:
7. ConraadsVM, Tavazzi L,SantiniMetal.Sensitivity andpositivepredic- e4622.
tivevalueofimplantableintrathoracicimpedancemonitoringasapredictor 19. PereiraTV,HorwitzRI,IoannidisJPA.Empiricalevaluationofverylarge
of heart failure hospitalizations: The SENSE-HF trial. Eur Heart J treatmenteffectsofmedicalinterventions.JAMA2012;308:1676–1684.
2011;32:2266–2273.
